GFACX
Price
$70.97
Change
+$0.35 (+0.50%)
Updated
Jul 14 closing price
Net Assets
322.6B
VCBCX
Price
$19.39
Change
+$0.06 (+0.31%)
Updated
Jul 14 closing price
Net Assets
1.03B
Interact to see
Advertisement

GFACX vs VCBCX

Header iconGFACX vs VCBCX Comparison
Open Charts GFACX vs VCBCXBanner chart's image
American Funds Growth Fund of Amer C
Price$70.97
Change+$0.35 (+0.50%)
VolumeN/A
Net Assets322.6B
VALIC Company I Systematic Growth
Price$19.39
Change+$0.06 (+0.31%)
VolumeN/A
Net Assets1.03B
GFACX vs VCBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GFACX vs. VCBCX commentary
Jul 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a StrongBuy and VCBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 323B vs. VCBCX (1.03B). VCBCX pays higher dividends than GFACX: VCBCX (0.08) vs GFACX (0.00). GFACX was incepted earlier than VCBCX: GFACX (24 years) vs VCBCX (25 years). GFACX (1.36) is less costly to investors than VCBCX (0.83). VCBCX is a more actively managed with annual turnover of: 56.00 vs. GFACX (25.00). VCBCX has a lower initial minimum investment than GFACX: VCBCX (0) vs GFACX (250). GFACX annual gain was more profitable for investors over the last year : 8.22 vs. VCBCX (3.19). GFACX return over 5 years is better than : 35.18 vs. VCBCX (-14.99).
GFACXVCBCXGFACX / VCBCX
Total Expense Ratio1.360.65209%
Annual Report Gross Expense Ratio1.360.83164%
Fund Existence24 years25 years-
Gain YTD11.308-3.312-341%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets323B1.03B31,390%
Annual Yield % from dividends0.000.08-
Returns for 1 year8.223.19258%
Returns for 3 years52.0424.42213%
Returns for 5 years35.18-14.99-235%
Returns for 10 years63.342.862,213%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FMCKJ14.670.02
+0.14%
Freddie Mac
CTOUF12.57N/A
N/A
Charter Hall Group
SLNCF1.60N/A
N/A
Silence Therapeutics, Plc.
TPRKY7.71-0.03
-0.37%
Travis Perkins Plc
CYCA0.02N/A
-6.17%
Cytta Corp.